Merel J. L'ami
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al.
Journal: Annals of the rheumatic diseases
Published: October 29, 2019
Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations.
Journal: European journal of clinical pharmacology
Published: August 29, 2019
The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients.
Journal: Rheumatology (Oxford, England)
Published: July 29, 2019
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial.
Journal: JMIR research protocols
Published: June 21, 2019
Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al.
Journal: Annals of the rheumatic diseases
Published: May 03, 2019
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
Journal: PloS one
Published: April 23, 2018
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
Journal: Science translational medicine
Published: March 07, 2018
Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
Journal: Annals of the rheumatic diseases
Published: November 03, 2017
Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab.
Journal: Scandinavian journal of rheumatology
Published: July 27, 2017
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.
Journal: Annals of the rheumatic diseases
Published: May 12, 2017
Last Updated: 09/26/2026